![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](lh2765contents.gif)
Acta Cryst. (2009). E65, o474-o475 [ doi:10.1107/S1600536809003766 ]
Abstract: The title compound, C11H13N2O+·Cl-·2H2O, the dihydrate of (+)-vasicinol hydrochloride, is a pyrrolidinoquinazoline alkaloid. It was isolated from the ethyl acetate fraction of the leaves of Peganum harmala L. The pyrrolidine ring has an envelope conformation with the C atom at position 2 acting as the flap and the C atom at position 3, carrying the hydroxyl substituent, has an S configuration. The absolute configuration was determined as a result of the anomalous scattering of the Cl atom. In the crystal structure, molecules stack along the a axis, connected to one another via intermolecular O-H
Cl and N-H
Cl hydrogen bonds, forming approximately triangular-shaped R21(7) rings, and O-H
Cl and O-H
O hydrogen bonds, forming pentagonal-shaped R54(10) rings. The overall effect is a ribbon-like arrangement running parallel to the a axis.
Online 6 February 2009
Copyright © International Union of Crystallography
IUCr Webmaster